NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

403 hedge funds and large institutions have $7.57B invested in Neurocrine Biosciences in 2021 Q4 according to their latest regulatory filings, with 72 funds opening new positions, 141 increasing their positions, 140 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
403
Holders Change
+10
Holders Change %
+2.54%
% of All Funds
6.22%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
72
Increased
141
Reduced
140
Closed
57
Calls
$44.6M
Puts
$52M
Net Calls
-$7.33M
Net Calls Change
-$60.4M

Top Buyers

1
BlackRock
1
BlackRock
New York
$977M
2
Ameriprise
2
Ameriprise
Minnesota
$60.2M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$37.2M
4
California Public Employees Retirement System
4
California Public Employees Retirement System
California
$53.6M
5
APM
5
Avidity Partners Management
Texas
$107M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$57.5M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$634M
3
PAMS
3
Pictet Asset Management (Switzerland)
Switzerland
$35M
4
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$9.41M
5
WP
5
Woodline Partners
California
$10.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
BBA
26
Baker Bros. Advisors
New York
$57.7M – – –
Fidelity Investments
27
Fidelity Investments
Massachusetts
$57.5M -$238M -2,790,506 -81%
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$53.6M +$35.7M +418,990 +200%
First Trust Advisors
29
First Trust Advisors
Illinois
$50.8M -$6.92M -81,261 -12%
Millennium Management
30
Millennium Management
New York
$47.8M +$5.94M +69,753 +14%
Nordea Investment Management
31
Nordea Investment Management
Sweden
$47.6M +$8.21M +96,375 +21%
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$45M +$32.3M +378,826 +254%
Charles Schwab
33
Charles Schwab
California
$43.4M +$1.07M +12,547 +3%
Bank of America
34
Bank of America
North Carolina
$43.1M -$7.19M -84,478 -14%
PA
35
Perceptive Advisors
New York
$41.1M – – –
GKIM
36
GW&K Investment Management
Massachusetts
$39.1M +$1.25M +14,733 +3%
Legal & General Group
37
Legal & General Group
United Kingdom
$38.1M -$251K -2,944 -0.7%
Adage Capital Partners
38
Adage Capital Partners
Massachusetts
$37.2M +$37.2M +437,000 New
Deutsche Bank
39
Deutsche Bank
Germany
$35.2M -$1.42M -16,655 -4%
PAMS
40
Pictet Asset Management (Switzerland)
Switzerland
$35M -$79.9M -938,417 -70%
PHS
41
PFM Health Sciences
California
$33.6M -$40M -470,021 -54%
BNP Paribas Asset Management
42
BNP Paribas Asset Management
France
$31.7M -$1.63M -19,158 -5%
HM
43
HealthCor Management
New York
$31.2M -$6.81M -80,002 -18%
Fiera Capital (Canada)
44
Fiera Capital (Canada)
Quebec, Canada
$31M -$3.29M -38,600 -10%
Swiss National Bank
45
Swiss National Bank
Switzerland
$30.6M -$1.13M -13,300 -4%
UBS AM
46
UBS AM
Illinois
$29.8M +$6.48M +76,040 +28%
Principal Financial Group
47
Principal Financial Group
Iowa
$28M -$282K -3,313 -1%
Balyasny Asset Management
48
Balyasny Asset Management
Illinois
$27.4M +$13.8M +162,064 +102%
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$26.5M +$1.74M +20,406 +7%
CS
50
Candriam SCA
Luxembourg
$26.4M +$19.5M +228,400 +280%
1
2
3 4 5